Ignite Creation Date:
2024-05-06 @ 3:31 PM
Last Modification Date:
2025-12-17 @ 8:06 AM
Study NCT ID:
NCT04666441
Status:
None
Last Update Posted:
2022-04-08 00:00:00
First Post:
2020-12-10 00:00:00
Brief Title:
COVID-19 Study Assessing the Virologic Efficacy of REGN10933+REGN10987 Across Different Dose Regimens in Adult Outpatients With SARS-CoV-2 Infection
Sponsor:
Regeneron Pharmaceuticals
Organization:
Regeneron Pharmaceuticals
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-12-15
Start Date Type:
ACTUAL
Primary Completion Date:
2021-03-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-09-21
Completion Date Type:
ACTUAL
First Submit Date:
2020-12-10 00:00:00
First Submit QC Date:
December 10 2020
Study First Post Date:
2020-12-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-03-03 00:00:00
Results First Submit QC Date:
None
Results First Post Date:
2022-04-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-24 00:00:00
Last Update Post Date:
2022-04-08 00:00:00
Last Update Post Date Type:
ACTUAL